Nicotinic receptor activation in human cerebral cortical interneurons: A mechanism for inhibition and disinhibition of neuronal networks

Journal of Neuroscience

Volumn 20, Issue 1, 2000, Pages 66-75

  Alkondon, Manickavasagom ^a   Pereira, Edna F R ^a   Eisenberg, Howard M ^a   Albuquerque, Edson X ^a,b  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Acetylcholine; Choline; Dihydro erythroidine; GABA; Methyllycaconitine; Patch clamp

Indexed keywords

4 AMINOBUTYRIC ACID; ACETYLCHOLINE; CHOLINE; DIHYDRO BETA ERYTHROIDINE; METHYLLYCACONITINE; NEUROTRANSMITTER; NICOTINIC RECEPTOR;

ADOLESCENT; ADULT; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; FEMALE; GABAERGIC SYSTEM; HUMAN; HUMAN TISSUE; INTERNEURON; MALE; NERVE CELL NETWORK; NERVE CELL STIMULATION; NERVE ENDING; NEUROTRANSMITTER RELEASE; PATCH CLAMP; POSTSYNAPTIC POTENTIAL; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0033995561     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.20-01-00066.2000     Document Type: Article

References (68)

1. Albuquerque EX, Alkondon M, Pereira EFR, Castro NG, Schrattenholz A, Barbosa CTF, Bonfante-Cabarcas R, Aracava Y, Eisenberg H, Maelicke A (1996) Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280:1117-1136.
2. Alkondon M, Pereira EFR. Barbosa CTF, Albuquerque EX (1997) Neuronal nicotinic acetylcholine receptor activation modulates γ-aminobutyric acid release from CA1 neurons of rat hippocampal slices. J Pharmacol Exp Ther 283:1396-1411.
3. Alkondon M, Pereira EFR, Albuquerque EX (1998) α-Bungarotoxin- and methyllycaconitine-sensitive nicotinic receptors mediate fast synaptic transmission in interneurons of rat hippocampal slices. Brain Res 810:257-263.
4. Alkondon M, Pereira EFR, Eisenberg HM, Albuquerque EX (1999) Choline and selective antagonists identify two subtypes of nicotinic acetylcholine receptors that modulate GABA release from CA1 interneurons in rat hippocampal slices. J Neurosci 19:2693-2705.
5. Arroyo-Jiménez MM, Bourgeois J-P, Marubio LM, Le Sourd A-M, Ottersen OP, Rinvik E, Fairén A, Changeux J-P (1999) Ultrastructural localization of the α4-subunit of the neuronal acetylcholine nicotinic receptor in the rat substantia nigra. J Neurosci 19:6475-6487.
6. Barbosa CTF, Alkondon M, Aracava Y, Maelicke A, Albuquerque EX (1996) Ligand-gated ion channels in acutely dissociated rat hippocampal neurons with long dendrites. Neurosci Lett 210:177-180.
7. Ben-Shlomo Y (1997) The epidemiology of Parkinson's disease. Ballieres Clin Neurol 6:55-68.
8. Bertolino M, Kellar KJ, Vicini S, Gillis RA (1997) Nicotinic receptor mediates spontaneous GABA release in the rat dorsal motor nucleus of the vagus. Neuroscience 79:671-681.
9. Changeux JP, Bertrand D. Corringer PJ, Dehaene S, Edelstein S, Léna C, Le Novère N, Marubio L, Picciotto M, Zoli M (1998) Brain nicotinic receptors: structure and regulation, role in learning and reinforcement. Brain Res Brain Res Rev 26:198-216.
10. Cummins TR, Jiang C, Haddad GG (1993) Human neocortical excitability is decreased during anoxia via sodium channel modulation. J Clin Invest 91:608-615.
11. Dalack GW, Healy DJ, Meador-Woodruff JH (1998) Nicotine dependence in schizophrenia: clinical phenomena and laboratory findings. Am J Psychiatry 155:1490-1501.
12. Dani JA, Heinemann S (1996) Molecular and cellular aspects of nicotine abuse. Neuron 16:905-908.
13. Dempster J (1989) Computer analysis of electrophysiological signals. In: Microcomputers in physiology: a practical approach (Frazer PJ, ed), pp 51-93, Oxford: IRI.
14. Elmslie FV, Rees M, Williamson MP, Kerr M, Kjeldsen MJ, Pang KA, Sundqvist A, Friis ML, Chadwick D, Richens A, Covanis A, Santos M, Arzimanoglou A, Panayiotopoulos CP, Curtis D, Whitehouse WP, Gardiner RM (1997) Genetic mapping of a major susceptibility locus for juvenile myoclonic epilepsy on chromosome 15q. Hum Mol Genet 6:1329-1334.
15. Ferraro L, Tanganelli S, Caló G, Antonelli T, Fabrizi A, Acciarri N, Bianchi C, Beani L, Simonato M (1993) Noradrenergic modulation of gamma-aminobutyric acid outflow from the human cerebral cortex. Brain Res 629:103-108.
16. Frazier CJ, Buhler AV, Weiner JL, Dunwiddie TV (1998) Synaptic potentials mediated via alpha-bungarotoxin-sensitive nicotinic acetylcholine receptors in rat hippocampal interneurons. J Neurosci 18:8228-8235.
17. Freedman R, Coon H, Myles Worsley M, Orr Urtreger A. Olincy A, Davis A, Polymcropoulos M. Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L. Leonard S, Byerley W (1997) Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci USA 94:587-592.
18. Galzin AM, Poirier MF, Lista A, Chodkiewicz JP, Blier P, Ramdine R, Loô H, Roux FX, Redondo A, Langer SZ (1992) Characterization of the 5-hydroxytryptamine receptor modulating the release of 5-[3H]hydroxytryptamine in slices of the human neocortex. J Neurochem 59:1293-1301.
19. Gerlach M, Gsell W, Kornhuber J, Jellinger K, Krieger V, Pantucek F, Vock R, Riederer P (1996) A post mortem study on neurochemical markers of dopaminergic, GABAergic and glutamatergic neurons in basal ganglia-thalamocortical circuits in Parkinson syndrome. Brain Res 741:142-152.
20. Gopalakrishnan M, Monteggia LM, Anderson DJ, Molinari EJ, Piattoni Kaplan M, Donnelly Roberts D, Arneric SP, Sullivan JP (1996) Stable expression, pharmacologic properties and regulation of the human neuronal nicotinic acetylcholine α4β2 receptor. J Pharmacol Exp Ther 276:289-297.
21. Gotti C, Fornasari D, Clementi F (1997) Human neuronal nicotinic receptors. Prog Neurobiol 53:199-237.
22. Gray R, Rajan AS, Radcliffe KA, Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 389:713-716.
23. Hagan JJ, Middlemiss DN, Sharpe PC. Poste GH (1997) Parkinson's disease: prospects for improved drug therapy. Trends Pharmacol Sci 18:156-163.
24. Halliwell JV (1989) Cholinergic responses in human neocortical neurones. EXS 57:138-149.
25. Hamill OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981) Improved patch-clamp techniques for high resolution current recording from cells and cell-free membrane patches. Pflügers Arch 39:85-100.
26. Hietala J, Syvälahti E (1996) Dopamine in schizophrenia. Ann Med 28:557-561.
27. Hilmas C, Alkondon M, Eisenberg HM, Albuquerque EX (1998) Nicotinic receptor activation modulates GABA release from neurons in human cortical slices. Soc Neurosci Abstr 24:1581.
28. Isokawa M (1996) Decrement of GABAA receptor-mediated inhibitory postsynaptic currents in dentate granule cells in epileptic hippocampus. J Neurophysiol 75:1901-1908.
29. Isokawa M, Levesque M, Fried I, Engel J (1997) Glutamate currents in morphologically identified human dentate granule cells in temporal lobe epilepsy. J Neurophysiol 77:3355-3369.
30. Kandel ER, Schwartz JH (1991) Directly gated transmission at central synapses. In: Principles of neural science (Kandel ER, Schwartz JH, Jessel TM, eds), pp 153-172. East Norwalk. CT: Appleton and Lange.
31. Kawaguchi Y (1993) Groupings of nonpyramidal and pyramidal cells with specific physiological and morphological characteristics in rat frontal cortex. J Neurophysiol 69:416-431.
32. 2+ permeability, conductance, and gating of human α4β2 nicotinic acetylcholine receptors. J Neurosci 17:9035-9047.
33. 2+ ions in nicotinic facilitation of GABA release in mouse thalamus. J Neurosci 17:576-585.
34. Léna C, Changeux JP, Mulle C (1993) Evidence for "preterminal" nicotinic receptors on GABAergic axons in the rat interpeduncular nucleus. J Neurosci 13:2680-2688.
35. Leonard S, Adams C, Breese CR, Adler LE, Bickford P, Byerley W, Coon H, Griffith JM, Miller C, Myles Worsley M, Nagamoto HT, Rollins Y, Stevens KE, Waldo M, Freedman R (1996) Nicotinic receptor function in schizophrenia. Schizophr Bull 22:431-445.
36. Levey AI (1996) Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. Proc Natl Acad Sci USA 93:13541-13546.
37. Levin ED, Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 138:217-230.
38. Lindstrom J, Anand R, Gerzanich V, Peng X, Wang F, Wells G (1996) Structure and function of neuronal nicotinic acetylcholine receptors. Prog Brain Res 109:125-137.
39. Lu Y, Grady S, Marks MJ, Picciotto M, Changeux JP, Collins AC (1998) Pharmacological characterization of nicotinic receptor-stimulated GABA release from mouse brain synaptosomes. J Pharmacol Exp Ther 287:648-657.
40. Mangan GL, Golding JF (1983) The effects of smoking on memory consolidation. J Psychol 115:65-77.
41. McMahon LL, Yoon KW, Chiappinelli VA (1994) Nicotinic receptor activation facilitates GABAergic neurotransmission in the avian lateral spiriform nucleus. Neuroscience 59:689-698.
42. Miyake A, Mochizuki S, Takemoto Y, Akuzawa S (1995) Molecular cloning of human 5-hydroxytryptamine3 receptor: heterogeneity in distribution and function among species. Mol Pharmacol 48:407-416.
43. Morens DM, Grandinetti A, Davis JW, Ross GW, White LR, Reed D (1996) Evidence against the operation of selective mortality in explaining the association between cigarette smoking and reduced occurrence of idiopathic Parkinson disease. Am J Epidemiol 144:400-404.
44. Newhouse PA, Potter A, Levin ED (1996) Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11:206-228.
45. Nguyen Q, Sapp DW, VanNess PC, Olsen RW (1995) Modulation of GABAA receptor binding in human brain by neuroactive steroids: species and brain regional differences. Synapse 19:77-87.
46. Nobili L, Sannita WG (1997) Cholinergic modulation, visual function and Alzheimer's dementia. Vision Res 37:3559-3571.
47. Parkin C, Fairweather DB, Shamsi Z, Stanley N, Hindmarch I (1998) The effects of cigarette smoking on overnight performance. Psychopharmacology (Berl) 136:172-178.
48. Peeke SC, Peeke HV (1984) Attention, memory, and cigarette smoking. Psychopharmacology (Berl) 84:205-216.
49. Peng X, Katz M, Gerzanich V, Anand R, Lindstrom J (1994) Human alpha 7 acetylcholine receptor: cloning of the alpha 7 subunit from the SH-SY5Y cell line and determination of pharmacological properties of native receptors and functional alpha 7 homomers expressed in Xenopus oocytes. Mol Pharmacol 45:546-554.
50. Pereira EFR, Barbosa CTF, Alkondon M, Rocha ES, Albuquerque EX, Eisenberg HM (1997) Ligand-gated ion channels on human neurons. Soc Neurosci Abstr 23:374.
51. Picciotto MR (1998) Common aspects of the action of nicotine and other drugs of abuse. Drug Alcohol Depend 51:165-172.
52. Pidoplichko V, DeBiasi M, Williams JT, Dani JA (1997) Nicotine activates and desensitizes midbrain dopamine neurons. Nature 390:401-404.
53. Radcliffe KA, Dani JA (1998) Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. J Neurosci 18:7075-7083.
54. Raiteri M, Marchi M, Paudice P (1990) Presynaptic muscarinic receptors in the central nervous system. Ann NY Acad Sci 604:113-129.
55. Rocrig B, Nelson DA, Katz LC (1997) Fast synaptic signaling by nicotinic acetylcholine and serotonin 5-HT3 receptors in developing visual cortex. J Neurosci 17:8353-8362.
56. Role LW, Berg DK (1996) Nicotinic receptors in the development and modulation of CNS synapses. Neuron 16:1077-1085.
57. Russo C, Marchi M, Andrioli GC, Cavazzani P, Raiteri M (1993) Enhancement of glycine release from human brain cortex synaptosomes by acetylcholine acting at M4 muscarinic receptors. J Pharmacol Exp Ther 266:142-146.
58. Rye DB (1997) Contributions of the pedunculopontine region to normal and altered REM sleep. Sleep 20:757-788.
59. Stein EA, Pankiewicz J, Harsch HH, Cho JK, Fuller SA, Hoffmann RG, Hawkins M, Rao SM, Bandettini PA, Bloom AS (1998) Nicotine-induced limbic cortical activation in the human brain: a functional MRI study. Am J Psychiatry 155:1009-1015.
60. Svoboda KR, Adams CE, Lupica CR (1999) Opioid receptor subtype expression defines morphologically distinct classes of hippocampal interneurons. J Neurosci 19:85-95.
61. van Kammen DP, Petty F, Kelley ME, Kramer GL, Barry EJ, Yao JK, Gurklis JA, Peters JL (1998) GABA and brain abnormalities in schizophrenia. Psychiatry Res 82:25-35.
62. Weinberger DR (1997) The biological basis of schizophrenia: new directions. J Clin Psychiatry 58:22-27.
63. Wevers A, Monteggia L, Nowacki S, Bloch W, Schütz U, Lindstrom J, Pereira EFR, Arneric S, Sullivan J, Eisenberg H, Giacobini E, Gass P, de Vos RAI, Jansen SEN H, Maelicke A, Albuquerque EX, Schröder H (1999) Expression of nicotinic acetylcholine receptor subunits in the cerebral cortex in Alzheimer's disease-histotopographical correlation with amyloid plaques and hyperphosphorylated tau-protein. Eur J Neurosci 11:2551-2555.
64. Whitehouse PJ, Kalaria RN (1995) Nicotinic receptors and neurodegenerative dementing diseases: basic research and clinical implications. Alzheimer Dis Assoc Disord 9:3-5.
65. 3H]nicotinic acetylcholine binding in Alzheimer's disease and Parkinson's disease: an autoradiographic study. Neurology 38:7211-723.
66. Wonnacott S (1997) Presynaptic nicotinic ACh receptors. Trends Neurosci 20:92-98.
67. Zhang M, Wang YT, Vyas DM, Neuman RS, Bieger D (1993) Nicotinic cholinoceptor-mediated excitatory postsynaptic potentials in rat nucleus ambiguus. Exp Brain Res 96:83-88.
68. Zilles K, Schröder H. Schröder U, Horvath E, Werner L, Luitcn PG, Maelicke A, Strosberg AD (1989) Distribution of cholinergic receptors in the rat and human neocortex. EXS 57:212-228.